Hallucinogen Persisting Perception Disorder and Risk of Suicide
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
A 30-year-old male patient developed a hallucinogen persisting perception disorder (HPPD) after smoking cannabis laced with phencyclidine (PCP) or lysergic acid diethylamide (LSD) 10 years prior to hospital admission. Clinically, he reported seeing vivid, saturated colors and caricature-like objects. The patient described perceiving objects or people in motion as moving faster than normal. He reported living in a dream-like state and feeling numb and detached from other people and his surroundings. Upon pharmacotherapy initiation, facility transfer, and subsequent discharge from an acute psychiatry unit, he ultimately committed suicide. Although hallucinogen abuse is common in the United States, this case suggests that HPPD maybe significantly underdiagnosed and undertreated. In some cases, this oversight may perpetuate years of unnecessary patient suffering and can ultimately lead to severe depression and suicide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Suicide after discharge from psychiatric inpatient care
Goldacre, M., Seagroatt, V, & Hawton, K. (1993) · The Lancet · doi:10.1016/0140-6736(93)91822-4 · Cited by 380 · cited 1×
“They concluded that the month after discharge proposes the highest risk and that specifically for men, the first day is the most crucial, with twice as high a risk of suicide compared to the rest of the month.(18) Several dynamics could be generated by from these data such as patients having a perceived loss of suppor…”
Background
Cited by
Psychedelics and Psychedelic-Assisted Psychotherapy
Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I., Kalin, N. H., McDonald, W. M., & and the Work Group on Biomarkers and Novel Treatments, A. D. O. T. A. P. A. C. O. R. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19010035 · Cited by 649
Martinotti, G., Santacroce, R., Pettorruso, M., Montemitro, C., Spano, M., Lorusso, M., Di Giannantonio, M., & Lerner, A. (2018) · Brain Sciences · doi:10.3390/brainsci8030047 · Cited by 171
“Zobor, 2015 [29] 1 Cannabis Gaillard, 2003 [46] 2 Cannabis Lerner, 2014 [47] 2 Cannabis (Synthetic) Anderson, 2017 [48] 1 Cannabis and MDMA Stress Brodrick, 2016 [49] 1 Cannabis and LSD Coppola, 2017 [50] 1 Cannabis (Synthetic, JWH-122) Cannabis consumption Lerner, 2003 [51] 16 LSD Lerner, 2002 [20] 1 LSD Lerner, 2000…”
BackgroundInfluentialOrsolini, L., Papanti, G. D., De Berardis, D., Guirguis, A., Corkery, J. M., & Schifano, F. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00240 · Cited by 99
“(31) Case report M, 30 years, presented to the emergency department after surviving two subsequent suicide attempts by”
BackgroundHallucinogenic persisting perception disorder: a case series and review of the literature.
Ford, H., Fraser, C. L., Solly, E., Clough, M., Fielding, J., White, O., & Van Der Walt, A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.878609 · Cited by 28
“Brodrick (22) LSD, natural THC, cocaine, PCP Altered motion perception, color enhancement, micropsia, macropsia MRI: mild abnormalities SSRI, AED, TeCA Suicide”
BackgroundDoyle, M. A., Ling, S., Lui, L. M. W., Fragnelli, P., Teopiz, K. M., Ho, R., Di Vincenzo, J. D., Rosenblat, J. D., Gillissie, E. S., Nogo, D., et al. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2063273 · Cited by 27
Metadata
- Authors
- Brodrick, J., & Mitchell, B. G.
- Venue
- Journal of Pharmacy Practice
- Publisher
- SAGE Publications
- Published
- 2016-07-09
- Volume
- 29
- Issue
- 4
- Pages
- 431-434
- ISSN
- 0897-1900 (ISSN-L)
- 1531-1937
- OpenAlex
- W2110193646
- Cited by
- 23
- References
- 1
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hallucinogen Persisting Perception Disorder and Risk of Suicide. https://app.cochat.ai/papers/10.1177/0897190014566314
- The paper
- Brodrick, J., & Mitchell, B. G. (2016). Hallucinogen Persisting Perception Disorder and Risk of Suicide. Journal of Pharmacy Practice. https://doi.org/10.1177/0897190014566314
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.